mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.03 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.03 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.04 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.04 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |